No records
|
520 |
Jamtani I., Nugroho A., Rahadiani N., Manangka R.S.W. |
57220165203;57192888914;16426455700;57222276868; |
Challenging retrovesical mass in men: Report of a rare liposarcoma case with concurrent COVID-19 infection |
2021 |
BMJ Case Reports |
14 |
3 |
e241466 |
|
|
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85102142953&doi=10.1136%2fbcr-2020-241466&partnerID=40&md5=d155998c0d1b2e9350e4a10623455925 |
Department of Surgery, Fatmawati Central General Hospital, Jakarta Selatan, DKI Jakarta, Indonesia; Anatomical Pathology Department, Faculty of Medicine, Universitas Indonesia/Cipto Mangunkusumo National Referral Hostpital, Jakarta, Indonesia; Radiology Department, Mayapada Hospital, DKI Jakarta, Indonesia |
Jamtani, I., Department of Surgery, Fatmawati Central General Hospital, Jakarta Selatan, DKI Jakarta, Indonesia; Nugroho, A., Department of Surgery, Fatmawati Central General Hospital, Jakarta Selatan, DKI Jakarta, Indonesia; Rahadiani, N., Anatomical Pathology Department, Faculty of Medicine, Universitas Indonesia/Cipto Mangunkusumo National Referral Hostpital, Jakarta, Indonesia; Manangka, R.S.W., Radiology Department, Mayapada Hospital, DKI Jakarta, Indonesia |
We describe a case of retrovesical liposarcoma in a male patient with concurrent COVID-19. A 50-year-old man had lower urinary tract symptoms and dull pain along his right gluteus. Due to COVID-19 infection, management was delayed. During self-isolation, the patient developed urinary retention and his pain level was an eight on the Visual Analogue Scale. A urinary catheter and an epidural catheter were inserted without any difficulty. Abdominal-pelvic MRI revealed a retrovesical mass suspected of liposarcoma with clear borders from surrounding organs. Following two consecutive negative SARS-CoV-2 PCR tests, we proceeded with surgery. Histopathology was dedifferentiated liposarcoma. Postoperatively, the patient suffered reactivation of COVID-19, and he was eventually discharged after two consecutive negative results on the PCR test on Post Operative Day (POD)-10. Retrovesical dedifferentiated liposarcoma is rare and considered as high-grade liposarcoma. Although surgery may exacerbate COVID-19 infection, surgical resection of symptomatic high-grade sarcoma is prioritised and performed as soon as no infection detected. © |
cancer intervention; COVID-19; pathology; radiology; surgery |
docetaxel; gemcitabine; adult; Article; bladder catheterization; case report; clinical article; common cold; comorbidity; coronavirus disease 2019; decreased appetite; differential diagnosis; echography; erythrocyte concentrate; fatigue; fever; follow up; histopathology; home quarantine; hospital discharge; human; human tissue; impaired bladder emptying; liposarcoma; lower urinary tract symptom; male; middle aged; multiple cycle treatment; myalgia; neurilemoma; nuclear magnetic resonance imaging; patient history of surgery; physical examination; polymerase chain reaction; positron emission tomography; recurrent disease; retrovesical liposarcoma; retrovesical liposarcoma; surgical approach; urine retention; virus reactivation; visual analog scale; adjuvant chemoradiotherapy; cancer grading; |
BMJ Publishing Group |
1757790X |
|
33653868 |
Article |
Q4 |
231 |
17583 |
|
|
527 |
Supali T., Djuardi Y., Christian M., Iskandar E., Alfian R., Maylasari R., Destani Y., Lomiga A., Minggu D., Lew D., Bogus J., Weil G.J., Fischer P.U. |
6602742029;6507800820;57209806543;57202299885;57222748640;57222744651;57222743128;57205724071;57202307524;57196371851;57170558700;7007028568;23567680200; |
An open label, randomized clinical trial to compare the tolerability and efficacy of ivermectin plus diethylcarbamazine and albendazole vs. Diethylcarbamazine plus albendazole for treatment of brugian filariasis in Indonesia |
2021 |
PLoS Neglected Tropical Diseases |
15 |
3 |
e0009294 |
|
|
|
2 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85103946402&doi=10.1371%2fjournal.pntd.0009294&partnerID=40&md5=bf67e831adfbad446acbda06b08e12de |
Department of Parasitology, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Universitas Nusa Cendana, Kupang, Lasiana, Kelapa lima, Kota Kupang, Indonesia; Nusa Tenggara Timur Provincial Health Office, Oebobo, Kota Kupang, Nusa Tenggara Timur, Indonesia; Division of Biostatistics, Washington University School of Medicine, St. Louis, MO, United States; Infectious Diseases Division, Department of Medicine, Washington University School of Medicine, St. Louis, MO, United States |
Supali, T., Department of Parasitology, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Djuardi, Y., Department of Parasitology, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Christian, M., Department of Parasitology, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Iskandar, E., Department of Parasitology, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Alfian, R., Department of Parasitology, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Maylasari, R., Department of Parasitology, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Destani, Y., Department of Parasitology, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Lomiga, A., Universitas Nusa Cendana, Kupang, Lasiana, Kelapa lima, Kota Kupang, Indonesia; Minggu, D., Nusa Tenggara Timur Provincial Health Office, Oebobo, Kota Kupang, Nusa Tenggara Timur, Indonesia; Lew, D., Division of Biostatistics, Washington University School of Medicine, St. Louis, MO, United States; Bogus, J., Infectious Diseases Division, Department of Medicine, Washington University School of Medicine, St. Louis, MO, United States; Weil, G.J., Infectious Diseases Division, Department of Medicine, Washington University School of Medicine, St. Louis, MO, United States; Fischer, P.U., Infectious Diseases Division, Department of Medicine, Washington University School of Medicine, St. Louis, MO, United States |
Improved treatments for lymphatic filariasis (LF) could accelerate the global elimination program for this disease. A triple drug combination of the anti-filarial drugs ivermectin, diethyl-carbamazine (DEC) and albendazole (IDA) has been shown to be safe and effective for achieving sustained clearance of microfilariae (Mf) of the filarial parasite Wuchereria ban-crofti from human blood. However, the triple drug combination has not been previously been evaluated for treatment of brugian filariasis, which accounts for about 10% of the global LF burden. This hospital-based clinical trial compared the safety and efficacy of IDA with that of the standard treatment (DEC plus albendazole, DA) in persons with Brugia timori infections on Sumba island, Indonesia. Fifty-five asymptomatic persons with B. timori Mf were treated with either a single oral dose of IDA (28 subjects) or with DEC plus albendazole (DA, 27 sub-jects). Participants were actively monitored for adverse events (AE) for two days after treatment by nurses and physicians who were masked regarding treatment assignments. Passive monitoring was performed by clinical teams that visited participant’s home villages for an additional five days. Microfilaremia was assessed by membrane filtration of 1 ml night blood at baseline, at 24h and one year after treatment. IDA was more effective than DA for completely clearing Mf at 24 hours (25/28, 89% vs. 8/27, 30%, P < 0.001). By 12 months after treatment, only one of 27 IDA recipients had Mf in their blood (4%) vs. 10 of 25 (40%) in persons treated with DA (P = 0.002). Approximately 90% of participants had antibodies to recombinant filarial antigen BmR1 at baseline. Antibody prevalence decreased to approximately 30% in both treatment groups at 12 months. About 45% of persons in both treatment groups experienced AE such as fever, muscle aches, lower back, joint and abdominal pain. These were mostly mild and most common during the first two days after treatment. No participant experienced a severe or serious AE. This study showed that IDA was well-tolerated and significantly more effective for clearing B. timori Mf from the blood than DA. Larger studies should be performed to further assess the safety and efficacy of IDA as a mass drug administration regimen to eliminate brugian filariasis. © 2021 Supali et al. |
|
albendazole; antifilarial agent; diethylcarbamazine; immunoglobulin G4; ivermectin; albendazole; antifilarial agent; diethylcarbamazine; ivermectin; protozoon antibody; abdominal pain; adult; antibody titer; arthralgia; Article; body mass; Brugia; Brugian filariasis; Burkholderia pseudomallei; combination drug therapy; controlled study; coughing; daily life activity; double blind procedure; dried blood spot testing; drowsiness; drug efficacy; drug safety; drug tolerability; female; fever; filariasis; follow up; gametocyte; headache; helminthiasis; human; Indonesia; leprosy; low back pain; lymphatic filariasis; major clinical study; male; mass drug administration; microfilariasis; myalgia; pharmacokinetics; Plasmodium falciparum; prevalence; questionnaire; randomized controlled trial; Schis |
Public Library of Science |
19352727 |
|
33780481 |
Article |
Q1 |
1990 |
1322 |
|
|
529 |
Kario K., Hoshide S., Chia Y.-C., Buranakitjaroen P., Siddique S., Shin J., Turana Y., Park S., Tsoi K., Chen C.-H., Cheng H.-M., Fujiwara T., Li Y., Huynh V.M., Nagai M., Nailes J., Sison J., Soenarta A.A., Sogunuru G.P., Sukonthasarn A., Tay J.C., Teo B.W., Verma N., Wang T.-D., Zhang Y., Wang J.-G. |
7102633390;6603859769;57204080905;6603376248;57210091066;54791393300;56083326000;8556278400;16065259000;7501963868;57026688600;57212076752;55931488300;57222327024;23498874000;57204676117;36764809200;6507634613;26428524900;12793132900;24330212600;23570166200;7102496979;7405566618;56183109800;57211730247; |
Guidance on ambulatory blood pressure monitoring: A statement from the HOPE Asia Network |
2021 |
Journal of Clinical Hypertension |
23 |
3 |
|
411 |
421 |
|
2 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85103146577&doi=10.1111%2fjch.14128&partnerID=40&md5=d75ac783dd0b799133a4ba32d9d8a571 |
Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan; Department of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Bandar Sunway, Malaysia; Department of Primary Care Medicine, Faculty of Medicine, University of Malaya Kuala, Lumpur, Malaysia; Division of Hypertension, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; Punjab Medical Center, Lahore, Pakistan; Faculty of Cardiology Service, Hanyang University Medical Center, Seoul, South Korea; School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia; Division of Cardiology, Cardiovascular Hospital, Yonsei Health System, Seoul, South Korea; JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong; Institute of Public Health and Community Medicine Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan; Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan; Center for Evidence-based Medicine, Department of Medical Education, Taipei Veterans General Hospital, Taipei, Taiwan; Centre for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Key Lab of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Department of Internal Medicine, University of Medicine and Pharmacy, Hue University, Viet Nam; Department of Internal Medicine, General Medicine and Cardiology, Hiroshima City Asa Hospital, Hiroshima, Japan; Department of Preventive and Community Medicine and Research Institute for Health Sciences, University of the East Ramon Magsaysay Memorial Medical Center Inc, Quezon City, Philippines; Section of Cardiology, Department of Medicine, Medical Center Manila, Manila, Philippines; Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia-National Cardiovascular Center, Harapan Kita, Jakarta, Indonesia; MIOT International Hospital, Chennai, India; College of Medical Sciences, Kathmandu University, Bharatpur, Nepal; Cardiology Division, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Thailand; Department of General Medicine, Tan Tock Seng Hospital, Singapore, Singapore; Division of Nephrology Department of Medicine, Yong Loo Lin School of Medicine, Singapore, Singapore; Department of Physiology, King George's Medical University, Lucknow, India; Cardiovascular Center and Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan; National Taiwan University Hospital, Taipei City, Taiwan; Division of Hospital Medicine, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan; Divisions of Hypertension and Heart Failure, Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Department of Hypertension, Centre for Epidemiological Studies and Clinical Trials, the Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China |
Kario, K., Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan; Hoshide, S., Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan; Chia, Y.-C., Department of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Bandar Sunway, Malaysia, Department of Primary Care Medicine, Faculty of Medicine, University of Malaya Kuala, Lumpur, Malaysia; Buranakitjaroen, P., Division of Hypertension, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; Siddique, S., Punjab Medical Center, Lahore, Pakistan; Shin, J., Faculty of Cardiology Service, Hanyang University Medical Center, Seoul, South Korea; Turana, Y., School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia; Park, S., Division of Cardiology, Cardiovascular Hospital, Yonsei Health System, Seoul, South Korea; Tsoi, K., JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong; Chen, C.-H., Institute of Public Health and Community Medicine Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan, Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan; Cheng, H.-M., Institute of Public Health and Community Medicine Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan, Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan, Center for Evidence-based Medicine, Department of Medical Education, Taipei Veterans General Hospital, Taipei, Taiwan; Fujiwara, T., Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan; Li, Y., Centre for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Key Lab of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Huynh, V.M., Department of Internal Medicine, University of Medicine and Pharmacy, Hue University, Viet Nam; Nagai, M., Department of Internal Medicine, General Medicine and Cardiology, Hiroshima City Asa Hospital, Hiroshima, Japan; Nailes, J., Department of Preventive and Community Medicine and Research Institute for Health Sciences, University of the East Ramon Magsaysay Memorial Medical Center Inc, Quezon City, Philippines; Sison, J., Section of Cardiology, Department of Medicine, Medical Center Manila, Manila, Philippines; Soenarta, A.A., Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia-National Cardiovascular Center, Harapan Kita, Jakarta, Indonesia; Sogunuru, G.P., MIOT International Hospital, Chennai, India, College of Medical Sciences, Kathmandu University, Bharatpur, Nepal; Sukonthasarn, A., Cardiology Division, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Thailand; Tay, J.C., Department of General Medicine, Tan Tock Seng Hospital, Singapore, Singapore; Teo, B.W., Division of Nephrology Department of Medicine, Yong Loo Lin School of Medicine, Singapore, Singapore; Verma, N., Department of Physiology, King George's Medical University, Lucknow, India; Wang, T.-D., Cardiovascular Center and Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan, National Taiwan University Hospital, Taipei City, Taiwan, Division of Hospital Medicine, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan; Zhang, Y., Divisions of Hypertension and Heart Failure, Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Wang, J.-G., Department of Hypertension, Centre for Epidemiological Studies and Clinical Trials, the Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China |
Hypertension is an important public health issue due to its association with a number of serious diseases, including cardiovascular disease and stroke. The importance of evaluating hypertension taking into account different blood pressure (BP) profiles and BP variability (BPV) is increasingly being recognized, and is particularly relevant in Asian populations given the specific features of hypertension in the region (including greater salt sensitivity and a high rate of nocturnal hypertension). Ambulatory BP monitoring (ABPM) is the gold standard for diagnosing hypertension and assessing 24-hour BP and provides data on several important parameters that cannot be obtained using any other form of BP measurement. In addition, ABPM parameters provide better information on cardio- and cerebrovascular risk than office BP. ABPM should be used in all patients with elevated BP, particularly those with unstable office or home BP, or who are suspected to have white-coat or masked hypertension. ABPM is also an important part of hypertension diagnosis and monitoring in high-risk patients. ABPM needs to be performed using a validated device and good practice techniques, and has a role both in hypertension diagnosis and in monitoring the response to antihypertensive therapy to ensure strict BP control throughout the 24-hour period. Use of ABPM in clinical practice may be limited by cost and accessibility, and practical education of physicians and patients is essential. The ABPM evidence and practice points in this document are based on the Hypertension Cardiovascular Outcome Prevention and Evidence (HOPE) Asia Network expert panel consensus recommendations for ABPM in Asia. © 2020 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC |
ambulatory blood pressure monitoring; blood pressure control; clinical practice; guidelines; hypertension |
angiotensin receptor antagonist; antihypertensive agent; calcium channel blocking agent; dipeptidyl carboxypeptidase inhibitor; antihypertensive agent; atherosclerosis; blood pressure monitoring; blood pressure regulation; blood pressure variability; brain hemorrhage; cardiovascular risk; circadian rhythm; cognitive defect; comorbidity; coronary artery disease; cost control; diastolic blood pressure; diastolic dysfunction; disease association; drug efficacy; health care access; heart left ventricle hypertrophy; high risk patient; human; low risk patient; masked hypertension; microangiopathy; prevalence; prognosis; reimbursement; Review; sensitivity and specificity; sleep disordered breathing; systolic blood pressure; telemedicine; treatment response; white coat hypertension; Asia; blood pr |
John Wiley and Sons Inc |
15246175 |
|
33319412 |
Review |
Q2 |
909 |
5078 |
|
|
532 |
Hoshide S., Kario K., Chia Y.-C., Siddique S., Buranakitjaroen P., Tsoi K., Tay J.C., Turana Y., Chen C.-H., Cheng H.-M., Huynh V.M., Park S., Soenarta A.A., Sogunuru G.P., Wang T.-D., Wang J.-G. |
6603859769;7102633390;57204080905;57210091066;6603376248;16065259000;24330212600;56083326000;7501963868;57026688600;57222327024;8556278400;6507634613;26428524900;7405566618;57211730247; |
Characteristics of hypertension in obstructive sleep apnea: An Asian experience |
2021 |
Journal of Clinical Hypertension |
23 |
3 |
|
489 |
495 |
|
2 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85102268392&doi=10.1111%2fjch.14184&partnerID=40&md5=801bd49c61521ab9e90707d5d59d804b |
Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan; Department of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Bandar Sunway, Malaysia; Department of Primary Care Medicine, Faculty of Medicine, University of Malaya Kuala, Lumpur, Malaysia; Punjab Medical Center, Lahore, Pakistan; Division of Hypertension, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong; Department of General Medicine, Tan Tock Seng Hospital, Singapore City, Singapore; School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia; Institute of Public Health and Community Medicine Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan; Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan; Department of Medical Education, Center for Evidence-based Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Department of Internal Medicine, University of Medicine and Pharmacy, Hue University, Viet Nam; Division of Cardiology, Cardiovascular Hospital, Yonsei Health System, Seoul, South Korea; Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia-National Cardiovascular Center, Jakarta, Indonesia; MIOT International Hospital, Chennai, India; College of Medical Sciences, Kathmandu University, Bharatpur, Nepal; Cardiovascular Center and Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan; Division of Hospital Medicine, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan; Department of Hypertension, Shanghai Key Laboratory of Hypertension, Centre for Epidemiological Studies and Clinical Trials, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China |
Hoshide, S., Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan; Kario, K., Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan; Chia, Y.-C., Department of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Bandar Sunway, Malaysia, Department of Primary Care Medicine, Faculty of Medicine, University of Malaya Kuala, Lumpur, Malaysia; Siddique, S., Punjab Medical Center, Lahore, Pakistan; Buranakitjaroen, P., Division of Hypertension, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; Tsoi, K., JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong; Tay, J.C., Department of General Medicine, Tan Tock Seng Hospital, Singapore City, Singapore; Turana, Y., School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia; Chen, C.-H., Institute of Public Health and Community Medicine Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan, Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan; Cheng, H.-M., Institute of Public Health and Community Medicine Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan, Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan, Department of Medical Education, Center for Evidence-based Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Huynh, V.M., Department of Internal Medicine, University of Medicine and Pharmacy, Hue University, Viet Nam; Park, S., Division of Cardiology, Cardiovascular Hospital, Yonsei Health System, Seoul, South Korea; Soenarta, A.A., Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia-National Cardiovascular Center, Jakarta, Indonesia; Sogunuru, G.P., MIOT International Hospital, Chennai, India, College of Medical Sciences, Kathmandu University, Bharatpur, Nepal; Wang, T.-D., Cardiovascular Center and Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan, Division of Hospital Medicine, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan; Wang, J.-G., Department of Hypertension, Shanghai Key Laboratory of Hypertension, Centre for Epidemiological Studies and Clinical Trials, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China |
Obstructive sleep apnea (OSA) is a risk of hypertension and is associated with cardiovascular disease (CVD) incidence. In Asian countries, the prevalence of OSA is high, as in Western countries. When blood pressure (BP) is evaluated in OSA individuals using ambulatory BP monitoring (ABPM), the BP phenotype often indicates abnormal BP variability, such as increased nighttime BP or abnormal diurnal BP variation, that is, non-dipper pattern, riser pattern, and morning BP surge, and all these conditions have been associated with increased CVD events. Asians have a higher prevalence of increased nighttime BP or morning BP surge than Westerners. Therefore, this review paper focused on OSA and hypertension from an Asian perspective to investigate the importance of the association between OSA and hypertension in the Asian population. Such abnormal BP variability has been shown to be associated with progression of arterial stiffness, and this association could provoke a vicious cycle between abnormal BP phenotypes and arterial stiffness, a phenomenon recognized as systemic hemodynamic atherothrombotic syndrome (SHATS). OSA may be one of the background factors that augment SHATS. An oxygen-triggered nocturnal oscillometric BP measurement device combined with a pulse oximeter for continuous SpO2 monitoring could detect BP variability caused by OSA. In addition to treating the OSA, accurate and reliable detection and treatment of any residual BP elevation and BP variability caused by OSA would be necessary to prevent CVD events. However, more detailed detection of BP variability, such as beat-by-beat BP monitoring, would further help to reduce CV events. © 2021 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC. |
blood pressure variability; hypertension; obstructive sleep apnea |
amlodipine; antihypertensive agent; atenolol; enalapril; hydrochlorothiazide; losartan; aerobic exercise; antihypertensive therapy; apnea hypopnea index; Asia; Asian; blood pressure; body mass; continuous positive airway pressure; follow up; human; hypertension; kidney denervation; lifestyle modification; obesity; polysomnography; primary hyperaldosteronism; Review; sleep disordered breathing; Asian continental ancestry group; blood pressure monitoring; hypertension; sleep disordered breathing; Asia; Asian Continental Ancestry Group; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Humans; Hypertension; Sleep Apnea, Obstructive |
John Wiley and Sons Inc |
15246175 |
|
33705599 |
Review |
Q2 |
909 |
5078 |
|
|
535 |
Zeziulin O., Mollan K.R., Shook-Sa B.E., Hanscom B., Lancaster K.E., Dumchev K., Go V.F., Chu V.A., Kiriazova T., Syarif Z., Dvoryak S., Reifeis S.A., Hamilton E., Sarasvita R., Rose S., Richardson P., Clarke W., Latkin C.A., Metzger D.S., Hoffman I.F., Miller W.C. |
55759565100;26659057900;55990940100;6603650318;55503210000;8923601900;7102536801;57195576444;55757875500;57216745876;15051444200;57193208279;56450237600;50462352200;12544917400;57203639655;16400885000;7006006751;35944632400;7006682600;57217026028; |
Depressive symptoms and use of HIV care and medication-assisted treatment among people with HIV who inject drugs |
2021 |
AIDS |
35 |
3 |
|
495 |
501 |
|
1 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85101895969&doi=10.1097%2fQAD.0000000000002774&partnerID=40&md5=dc8da3aef65727a23f50b2418240ffe3 |
Ukrainian Institute on Public Health Policy, Kyiv, Ukraine; School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States; Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States; Statistical Center for HIV/AIDS Research and Prevention (SCHARP), Fred Hutchinson Cancer Research Center, Seattle, WA, United States; College of Public Health, The Ohio State University, Columbus, OH, United States; UNC Vietnam, Ho Chi Minh City, Viet Nam; Abhipraya Foundation, Department Psychiatry, Faculty of Medicine, University of Indonesia, Depok, Indonesia; Family Health International (FHI 360), Durham, NC, United States; Indonesia National Narcotics Board, Abhipraya Foundation, East Jakarta, Indonesia; Johns Hopkins University, Baltimore, MD, United States; University of Pennsylvania, Philadelphia, PA, United States |
Zeziulin, O., Ukrainian Institute on Public Health Policy, Kyiv, Ukraine; Mollan, K.R., School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States, Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States; Shook-Sa, B.E., Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States; Hanscom, B., Statistical Center for HIV/AIDS Research and Prevention (SCHARP), Fred Hutchinson Cancer Research Center, Seattle, WA, United States; Lancaster, K.E., College of Public Health, The Ohio State University, Columbus, OH, United States; Dumchev, K., Ukrainian Institute on Public Health Policy, Kyiv, Ukraine; Go, V.F., Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States; Chu, V.A., UNC Vietnam, Ho Chi Minh City, Viet Nam; Kiriazova, T., Ukrainian Institute on Public Health Policy, Kyiv, Ukraine; Syarif, Z., Abhipraya Foundation, Department Psychiatry, Faculty of Medicine, University of Indonesia, Depok, Indonesia; Dvoryak, S., Ukrainian Institute on Public Health Policy, Kyiv, Ukraine; Reifeis, S.A., Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States; Hamilton, E., Family Health International (FHI 360), Durham, NC, United States; Sarasvita, R., Indonesia National Narcotics Board, Abhipraya Foundation, East Jakarta, Indonesia; Rose, S., Family Health International (FHI 360), Durham, NC, United States; Richardson, P., Johns Hopkins University, Baltimore, MD, United States; Clarke, W., Johns Hopkins University, Baltimore, MD, United States; Latkin, C.A., University of Pennsylvania, Philadelphia, PA, United States; Metzger, D.S., University of Pennsylvania, Philadelphia, PA, United States; Hoffman, I.F., School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States; Miller, W.C., College of Public Health, The Ohio State University, Columbus, OH, United States |
Objective: Vietnam, Indonesia, and Ukraine have major burdens of IDU and HIV. We estimated the prevalence of depressive symptoms at baseline among people living with HIV who inject drugs, evaluated associations between depression at baseline and 12-month HIV care outcomes and medication-assisted treatment (MAT), and evaluated the study intervention effect by baseline depression subgroups. Design: HPTN 074 was a randomized study. The study intervention included psychosocial counseling, systems navigation, and antiretroviral treatment (ART) at any CD4þ cell count. Methods: Moderate-to-severe depression was defined as a Patient Health Questionnaire-9 score of 10 or above. ART and MAT were self-reported. Eligibility criteria were: 18–60 years of age, active IDU, and viral load of at least 1000 copies/ml. Adjusted probability differences (aPD) were estimated using inverse-probability weighting. Results: A total of 502 participants enrolled from April 2015 to June 2016. Median age was 35 years; 85% identified as men. Prevalence of baseline moderate-to-severe depression was 14% in Vietnam, 14% in Indonesia, and 56% in Ukraine. No evident associations were detected between baseline depression and ART, viral suppression, or MAT at 12-month follow-up. The study intervention improved the proportions of people who inject drugs achieving 12-month viral suppression in both the depressed [intervention 44%; standard of care 24%; estimated aPD ¼ 25% (95% confidence interval: 4.0%, 45%)] and nondepressed subgroups [intervention 38%; standard of care 24%; aPD ¼ 13% (95% confidence interval: 2.0%, 25%)]. Conclusion: High levels of depressive symptoms were common among people living with HIV who inject drugs in Ukraine but were less common in Vietnam and Indonesia. The study intervention was effective among participants with or without baseline depression symptoms. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved. |
Antiretroviral therapy; Depression; Drug users; HIV; Opioid medication assisted treatment; Viral load |
antiretrovirus agent; CD4 antigen; drug; adult; antiretroviral therapy; Article; CD4 lymphocyte count; cohort analysis; controlled study; depression; disease burden; disease severity; female; follow up; health care quality; human; Human immunodeficiency virus infected patient; Human immunodeficiency virus infection; Indonesia; injection drug user; major clinical study; male; mortality; mortality rate; nonhuman; outcome assessment; patient care; patient counseling; Patient Health Questionnaire 9; prevalence; psychosocial care; randomized controlled trial; Ukraine; Viet Nam; virus inhibition; virus load; complication; depression; Adult; Depression; HIV Infections; Humans; Indonesia; Male; Pharmaceutical Preparations; Ukraine; Vietnam; Viral Load |
Lippincott Williams and Wilkins |
02699370 |
|
33252489 |
Article |
Q1 |
2195 |
1133 |
|
|
537 |
Huang J.-F., Li Y., Shin J., Chia Y.-C., Sukonthasarn A., Turana Y., Chen C.-H., Cheng H.-M., Ann Soenarta A., Tay J.C., Wang T.-D., Kario K., Wang J.-G., the HOPE Asia Network |
57215634442;55931488300;54791393300;57204080905;12793132900;56083326000;7501963868;57026688600;56545726300;24330212600;7405566618;7102633390;57211730247; |
Characteristics and control of the 24-hour ambulatory blood pressure in patients with metabolic syndrome |
2021 |
Journal of Clinical Hypertension |
23 |
3 |
|
450 |
456 |
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85101762609&doi=10.1111%2fjch.14229&partnerID=40&md5=e26837f3a812c95b88ec3427586cac58 |
Department of Cardiovascular Medicine, Shanghai Key Lab of Hypertension, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Faculty of Cardiology Service, Hanyang University Medical Center, Seoul, South Korea; Department of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Bandar Sunway, Malaysia; Department of Primary Care Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; Department of Internal Medicine, Cardiology Division, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia; Institute of Public Health and Community Medicine Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan; Department of Medicine, Division of Cardiology, Taipei Veterans General Hospital, Taipei, Taiwan; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan; Department of Medical Education, Center for Evidence-based Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia-National Cardiovascular Center, Harapan Kita, Jakarta, Indonesia; Department of General Medicine, Tan Tock Seng Hospital, Singapore, Singapore; Department of Internal Medicine, Cardiovascular Center and Division of Cardiology, National Taiwan University Hospital, Taipei City, Taiwan; Department of Internal Medicine, Division of Hospital Medicine, National Taiwan University Hospital, Taipei City, Taiwan; Department of Medicine, Division of Cardiovascular Medicine, Jichi Medical University School of Medicine, Tochigi, Japan |
Huang, J.-F., Department of Cardiovascular Medicine, Shanghai Key Lab of Hypertension, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Li, Y., Department of Cardiovascular Medicine, Shanghai Key Lab of Hypertension, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Shin, J., Faculty of Cardiology Service, Hanyang University Medical Center, Seoul, South Korea; Chia, Y.-C., Department of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Bandar Sunway, Malaysia, Department of Primary Care Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; Sukonthasarn, A., Department of Internal Medicine, Cardiology Division, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Turana, Y., School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia; Chen, C.-H., Institute of Public Health and Community Medicine Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan, Department of Medicine, Division of Cardiology, Taipei Veterans General Hospital, Taipei, Taiwan, Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan; Cheng, H.-M., Institute of Public Health and Community Medicine Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan, Department of Medicine, Division of Cardiology, Taipei Veterans General Hospital, Taipei, Taiwan, Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan, Department of Medical Education, Center for Evidence-based Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Ann Soenarta, A., Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia-National Cardiovascular Center, Harapan Kita, Jakarta, Indonesia; Tay, J.C., Department of General Medicine, Tan Tock Seng Hospital, Singapore, Singapore; Wang, T.-D., Department of Internal Medicine, Cardiovascular Center and Division of Cardiology, National Taiwan University Hospital, Taipei City, Taiwan, Department of Internal Medicine, Division of Hospital Medicine, National Taiwan University Hospital, Taipei City, Taiwan; Kario, K., Department of Medicine, Division of Cardiovascular Medicine, Jichi Medical University School of Medicine, Tochigi, Japan; Wang, J.-G., Department of Cardiovascular Medicine, Shanghai Key Lab of Hypertension, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; the HOPE Asia Network |
Asian countries are facing an increasing prevalence of metabolic syndrome (MetS), which may aggravate the burden of cardiovascular diseases in this region. MetS is closely associated with ambulatory blood pressure (BP). Patients with MetS, compared to those without, had a twofold higher risk of new-onset office, home, or ambulatory hypertension. Furthermore, the risk of new-onset MetS in patients with white-coat, masked and sustained hypertension was also doubled compared to normotensives. High-risk masked hypertension and blunted nighttime BP dipping are common in patients with MetS, suggesting perfect 24-hour BP control with long-acting antihypertensive drugs and early initiation of combination therapy might be especially important for patients with MetS. © 2021 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC. |
ambulatory blood pressure monitoring; antihypertensive treatment; masked hypertension; metabolic syndrome; non-dipping |
amlodipine; antidiabetic agent; antihypertensive agent; hydrochlorothiazide; hydroxymethylglutaryl coenzyme A reductase inhibitor; losartan; ramipril; sodium glucose cotransporter 2 inhibitor; zofenopril; abdominal obesity; blood pressure monitoring; clinical feature; diabetes mellitus; disease association; disease control; high risk patient; human; hyperglycemia; hypertension; metabolic syndrome X; prevalence; Review; risk assessment; waist circumference; white coat hypertension; Asia; blood pressure; blood pressure monitoring; hypertension; masked hypertension; metabolic syndrome X; Asia; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Humans; Hypertension; Masked Hypertension; Metabolic Syndrome |
John Wiley and Sons Inc |
15246175 |
|
33629806 |
Review |
Q2 |
909 |
5078 |
|
|
540 |
Chia Y.-C., Turana Y., Sukonthasarn A., Zhang Y., Shin J., Cheng H.-M., Tay J.C., Tsoi K., Siddique S., Verma N., Buranakitjaroen P., Sogunuru G.P., Nailes J., Van Minh H., Park S., Teo B.W., Chen C.-H., Wang T.-D., Soenarta A.A., Hoshide S., Wang J.-G., Kario K., the Hypertension Cardiovascular Outcome Prevention, Evidence (HOPE) Asia Network |
57204080905;56083326000;12793132900;56183109800;54791393300;57026688600;24330212600;16065259000;57210091066;7102496979;6603376248;26428524900;57204676117;57211946145;8556278400;23570166200;7501963868;7405566618;6507634613;6603859769;57211730247;7102633390; |
Comparison of guidelines for the management of hypertension: Similarities and differences between international and Asian countries; perspectives from HOPE-Asia Network |
2021 |
Journal of Clinical Hypertension |
23 |
3 |
|
422 |
434 |
|
2 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85101598138&doi=10.1111%2fjch.14226&partnerID=40&md5=3615334261cf54af8eb6d23b4967e99b |
Department of Medical Sciences, School of Medical and Life Sciences, Sunway University, Bandar Sunway, Malaysia; Department of Primary Care Medicine, Faculty of Medicine, University of Malaya Kuala, Lumpur, Malaysia; School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia; Cardiology Division, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Division of Hypertension and Heart Failure, Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Faculty of Cardiology Service, Hanyang University Medical Center, Seoul, South Korea; Institute of Public Health and Community Medicine Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan; Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan; Center for Evidence-Based Medicine, Department of Medical Education, Taipei Veterans General Hospital, Taipei, Taiwan; Department of General Medicine, Tan Tock Seng Hospital, Singapore; JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong; Punjab Medical Center, Lahore, Pakistan; Department of Physiology, King George's Medical University, Lucknow, India; Division of Hypertension, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; MIOT International Hospital, Chennai, India; College of Medical Sciences, Kathmandu University, Bharatpur, Nepal; University of the East Ramon Magsaysay Memorial Medical Center Inc., Quezon City, Philippines; Department of Internal Medicine, University of Medicine and Pharmacy, Hue University, Hue, Viet Nam; Division of Cardiology, Cardiovascular Hospital, Yonsei Health System, Seoul, South Korea; Division of Nephrology Department of Medicine, Yong Loo Lin School of Medicine, Singapore; Cardiovascular Center and Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan; Division of Hospital Medicine, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan; Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia-National Cardiovascular Center, Jakarta, Indonesia; Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan; Department of Hypertension, Centre for Epidemiological Studies and Clinical Trials, The Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China |
Chia, Y.-C., Department of Medical Sciences, School of Medical and Life Sciences, Sunway University, Bandar Sunway, Malaysia, Department of Primary Care Medicine, Faculty of Medicine, University of Malaya Kuala, Lumpur, Malaysia; Turana, Y., School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia; Sukonthasarn, A., Cardiology Division, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Zhang, Y., Division of Hypertension and Heart Failure, Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Shin, J., Faculty of Cardiology Service, Hanyang University Medical Center, Seoul, South Korea; Cheng, H.-M., Institute of Public Health and Community Medicine Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan, Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan, Center for Evidence-Based Medicine, Department of Medical Education, Taipei Veterans General Hospital, Taipei, Taiwan; Tay, J.C., Department of General Medicine, Tan Tock Seng Hospital, Singapore; Tsoi, K., JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong; Siddique, S., Punjab Medical Center, Lahore, Pakistan; Verma, N., Department of Physiology, King George's Medical University, Lucknow, India; Buranakitjaroen, P., Division of Hypertension, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; Sogunuru, G.P., MIOT International Hospital, Chennai, India, College of Medical Sciences, Kathmandu University, Bharatpur, Nepal; Nailes, J., University of the East Ramon Magsaysay Memorial Medical Center Inc., Quezon City, Philippines; Van Minh, H., Department of Internal Medicine, University of Medicine and Pharmacy, Hue University, Hue, Viet Nam; Park, S., Division of Cardiology, Cardiovascular Hospital, Yonsei Health System, Seoul, South Korea; Teo, B.W., Division of Nephrology Department of Medicine, Yong Loo Lin School of Medicine, Singapore; Chen, C.-H., Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan, Center for Evidence-Based Medicine, Department of Medical Education, Taipei Veterans General Hospital, Taipei, Taiwan; Wang, T.-D., Cardiovascular Center and Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan, Division of Hospital Medicine, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan; Soenarta, A.A., Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia-National Cardiovascular Center, Jakarta, Indonesia; Hoshide, S., Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan; Wang, J.-G., Department of Hypertension, Centre for Epidemiological Studies and Clinical Trials, The Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Kario, K., Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan; the Hypertension Cardiovascular Outcome Prevention, Evidence (HOPE) Asia Network |
Guidelines on the management of hypertension have been developed by various professional bodies and institutions to primarily address the issues of diagnosis, treatment, and control in order to rationalize and improve the management of hypertension. Hypertension guidelines across the world have recently been updated following the new and controversial lower blood pressure threshold of ≥130/80 mmHg for the diagnosis of hypertension adopted by the Americans. While there are differences between the major as well as between the Asian national guidelines, there were also many similarities. This paper discusses and highlights the differences and similarities between the major international guidelines of the American College of Cardiology/American Heart Association, of the European Society of Cardiology/European Society of Hypertension, and of the International Society of Hypertension and also compares them with the Asian guidelines. © 2021 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC. |
Asian countries; diagnosis; guidelines; HOPE-Asia Network; hypertension; target blood pressure |
angiotensin receptor antagonist; beta adrenergic receptor blocking agent; calcium channel blocking agent; dipeptidyl carboxypeptidase inhibitor; diuretic agent; Asia; blood pressure measurement; blood pressure monitoring; cardiovascular risk; cerebrovascular accident; chronic kidney failure; chronology; coronary artery disease; decision making; diabetes mellitus; Europe; geographic distribution; geriatrics; heart failure; Hong Kong; human; hypertension; India; Indonesia; Malaysia; medical society; multiple sclerosis; Pakistan; Philippines; practice guideline; Review; risk assessment; Singapore; Taiwan; Thailand; United States; Viet Nam; blood pressure; cardiology; hypertension; hypotension; American Heart Association; Asia; Blood Pressure; Cardiology; Humans; Hypertension; Hypotension; Uni |
John Wiley and Sons Inc |
15246175 |
|
33634570 |
Review |
Q2 |
909 |
5078 |
|
|
541 |
Fujiwara T., Hoshide S., Tomitani N., Cheng H.-M., Soenarta A.A., Turana Y., Chen C.-H., Minh H.V., Sogunuru G.P., Tay J.C., Wang T.-D., Chia Y.-C., Verma N., Li Y., Wang J.-G., Kario K. |
57212076752;6603859769;57189644362;57026688600;6507634613;56083326000;7501963868;57211946145;26428524900;24330212600;7405566618;57204080905;7102496979;55931488300;57211730247;7102633390; |
Clinical significance of nocturnal home blood pressure monitoring and nocturnal hypertension in Asia |
2021 |
Journal of Clinical Hypertension |
23 |
3 |
|
457 |
466 |
|
4 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85101488308&doi=10.1111%2fjch.14218&partnerID=40&md5=d3540818497da0e2ae884c08bf5b5ad6 |
Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Shimotsuke, Japan; Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan; Institute of Public Health and Community Medicine Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan; Center for Evidence-Based Medicine, Department of Medical Education, Taipei Veterans General Hospital, Taipei, Taiwan; Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia-National Cardiovascular Center, Jakarta, Indonesia; Faculty of Medical and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia; Department of Internal Medicine, University of Medicine and Pharmacy, Hue University, Hue, Viet Nam; Department of Cardiology, MIOT International Hospital, Chennai, India; College of Medical Sciences, Kathmandu University, Bharatpur, Nepal; Department of General Medicine, Tan Tock Seng Hospital, Singapore, Singapore; Cardiovascular Center and Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan; Division of Hospital Medicine, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan; Department of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Bandar Sunway, Malaysia; Department of Primary Care Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; Department of Physiology, King George's Medical University, Lucknow, India; Department of Hypertension, Centre for Epidemiological Studies and Clinical Trials, The Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China |
Fujiwara, T., Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Shimotsuke, Japan; Hoshide, S., Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Shimotsuke, Japan; Tomitani, N., Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Shimotsuke, Japan; Cheng, H.-M., Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan, Institute of Public Health and Community Medicine Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan, Center for Evidence-Based Medicine, Department of Medical Education, Taipei Veterans General Hospital, Taipei, Taiwan; Soenarta, A.A., Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia-National Cardiovascular Center, Jakarta, Indonesia; Turana, Y., Faculty of Medical and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia; Chen, C.-H., Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan, Institute of Public Health and Community Medicine Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan; Minh, H.V., Department of Internal Medicine, University of Medicine and Pharmacy, Hue University, Hue, Viet Nam; Sogunuru, G.P., Department of Cardiology, MIOT International Hospital, Chennai, India, College of Medical Sciences, Kathmandu University, Bharatpur, Nepal; Tay, J.C., Department of General Medicine, Tan Tock Seng Hospital, Singapore, Singapore; Wang, T.-D., Cardiovascular Center and Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan, Division of Hospital Medicine, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan; Chia, Y.-C., Department of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Bandar Sunway, Malaysia, Department of Primary Care Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; Verma, N., Department of Physiology, King George's Medical University, Lucknow, India; Li, Y., Department of Hypertension, Centre for Epidemiological Studies and Clinical Trials, The Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Wang, J.-G., Department of Hypertension, Centre for Epidemiological Studies and Clinical Trials, The Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Kario, K., Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Shimotsuke, Japan |
Nocturnal home blood pressure (BP) monitoring has been used in clinical practice for ~20 years. The authors recently showed that nocturnal systolic BP (SBP) measured by a home BP monitoring (HBPM) device in a Japanese general practice population was a significant predictor of incident cardiovascular disease (CVD) events, independent of office and morning home SBP levels, and that masked nocturnal hypertension obtained by HBPM (defined as nocturnal home BP ≥ 120/70 mmHg and average morning and evening BP < 135/85 mmHg) was associated with an increased risk of CVD events compared with controlled BP (nocturnal home BP < 120/70 mmHg and average morning and evening BP < 135/85 mmHg). This evidence revealed that (a) it is feasible to use a nocturnal HBPM device for monitoring nocturnal BP levels, and (b) such a device may offer an alternative to ambulatory BP monitoring, which has been the gold standard for the measurement of nocturnal BP. However, many unresolved clinical problems remain, such as the measurement schedule and conditions for the use of nocturnal HBPM. Further investigation of the measurement of nocturnal BP using an HBPM device and assessments of the prognostic value are thus warranted. Asians are at high risk of developing nocturnal hypertension due to high salt sensitivity and salt intake, and the precise management of their nocturnal BP levels is important. Information and communication technology-based monitoring devices are expected to facilitate the management of nocturnal hypertension in Asian populations. © 2021 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC |
Asia; blood pressure; blood pressure monitoring; nocturnal home blood pressure; nocturnal hypertension |
albumin to creatinine ratio; Asia; blood pressure measurement; blood pressure monitoring; blood pressure regulation; cardiovascular disease; clinical feature; clinical research; diagnostic value; feasibility study; general practice; gold standard; high risk population; human; hypertension; Japanese (people); medical informatics; nocturnal home blood pressure monitoring; nocturnal hypertension; organ injury; pathophysiology; prognosis; Review; salt intake; systolic blood pressure; target organ damage; blood pressure; blood pressure monitoring; hypertension; masked hypertension; Asia; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Humans; Hypertension; Masked Hypertension |
John Wiley and Sons Inc |
15246175 |
|
33591641 |
Review |
Q2 |
909 |
5078 |
|
|
546 |
Siste K., Sen L.T. |
55644113100;57219034101; |
Ascending Pattern of Alcohol Use and Underage Drinking in Asia: A Commentary on the Article by Assanangkornchai and Vichitkunakorn (2020) |
2021 |
Alcoholism: Clinical and Experimental Research |
45 |
3 |
|
496 |
499 |
|
1 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85100845814&doi=10.1111%2facer.14556&partnerID=40&md5=c99d4fa613d254d149143468117898a3 |
Department of Psychiatry, Faculty of Medicine, Universitas Indonesia – Cipto Mangunkusumo General Hospital, Jakarta, Indonesia |
Siste, K., Department of Psychiatry, Faculty of Medicine, Universitas Indonesia – Cipto Mangunkusumo General Hospital, Jakarta, Indonesia; Sen, L.T., Department of Psychiatry, Faculty of Medicine, Universitas Indonesia – Cipto Mangunkusumo General Hospital, Jakarta, Indonesia |
[No abstract available] |
|
alcohol; adolescent; adulthood; advertising; alcohol consumption; alcohol intoxication; alcohol withdrawal syndrome; alcoholic beverage; alcoholism; brain cortex; brain stem; corpus callosum; cultural factor; depression; drinking behavior; environmental factor; female; gray matter volume; groups by age; hippocampus; human; India; Indonesia; limbic cortex; male; mortality; Note; peer pressure; prefrontal cortex; prevalence; priority journal; psychological resilience; sex difference; social psychology; Southeast Asia; suicide attempt; Thailand; trend study; underage drinking; white matter; World Health Organization |
Blackwell Publishing Ltd |
01456008 |
|
33486766 |
Note |
Q1 |
1267 |
3019 |
|
|
547 |
Tsoi K., Yiu K., Lee H., Cheng H.-M., Wang T.-D., Tay J.-C., Teo B.W., Turana Y., Soenarta A.A., Sogunuru G.P., Siddique S., Chia Y.-C., Shin J., Chen C.-H., Wang J.-G., Kario K., the HOPE Asia Network |
16065259000;24167446900;57271749300;57026688600;7405566618;24330212600;23570166200;56083326000;6507634613;26428524900;57210091066;57204080905;54791393300;7501963868;57211730247;7102633390; |
Applications of artificial intelligence for hypertension management |
2021 |
Journal of Clinical Hypertension |
23 |
3 |
|
568 |
574 |
|
4 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85100377966&doi=10.1111%2fjch.14180&partnerID=40&md5=cdd3526a471a2db59f4ca490ffd9d59b |
SH Big Data Decision and Analytics Research Centre, Shatin, Hong Kong; JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong; Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan; Institute of Public Health and Community Medicine Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan; Center for Evidence-based Medicine, Department of Medical Education, Taipei Veterans General Hospital, Taipei, Taiwan; Cardiovascular Center and Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan; Division of Hospital Medicine, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan; Department of General Medicine, Tan Tock Seng Hospital, Singapore, Singapore; Division of Nephrology Department of Medicine, Yong Loo Lin School of Medicine, Singapore, Singapore; Department of Neurology, School of Medicine and health Sciences, Atma Jaya Catholic University of Indonesia, Indonesia; Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; Department of Cardiology, MIOT international hospital, Chennai, India; Punjab Medical Center, Lahore, Pakistan; Department of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Bandar Sunway, Malaysia; Faculty of Medicine, Department of Primary Care Medicine, University of Malaya, Kuala Lumpur, Malaysia; Faculty of Cardiology Service, Hanyang University Medical Center, Seoul, South Korea; Department of Hypertension, Centre for Epidemiological Studies and Clinical Trials, The Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan |
Tsoi, K., SH Big Data Decision and Analytics Research Centre, Shatin, Hong Kong, JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong; Yiu, K., SH Big Data Decision and Analytics Research Centre, Shatin, Hong Kong; Lee, H., JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong; Cheng, H.-M., Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan, Institute of Public Health and Community Medicine Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan, Center for Evidence-based Medicine, Department of Medical Education, Taipei Veterans General Hospital, Taipei, Taiwan; Wang, T.-D., Cardiovascular Center and Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan, Division of Hospital Medicine, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan; Tay, J.-C., Department of General Medicine, Tan Tock Seng Hospital, Singapore, Singapore; Teo, B.W., Division of Nephrology Department of Medicine, Yong Loo Lin School of Medicine, Singapore, Singapore; Turana, Y., Department of Neurology, School of Medicine and health Sciences, Atma Jaya Catholic University of Indonesia, Indonesia; Soenarta, A.A., Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; Sogunuru, G.P., Department of Cardiology, MIOT international hospital, Chennai, India; Siddique, S., Punjab Medical Center, Lahore, Pakistan; Chia, Y.-C., Department of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Bandar Sunway, Malaysia, Faculty of Medicine, Department of Primary Care Medicine, University of Malaya, Kuala Lumpur, Malaysia; Shin, J., Faculty of Cardiology Service, Hanyang University Medical Center, Seoul, South Korea; Chen, C.-H., Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Wang, J.-G., Department of Hypertension, Centre for Epidemiological Studies and Clinical Trials, The Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Kario, K., Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan; the HOPE Asia Network |
The prevalence of hypertension is increasing along with an aging population, causing millions of premature deaths annually worldwide. Low awareness of blood pressure (BP) elevation and suboptimal hypertension diagnosis serve as the major hurdles in effective hypertension management. The advent of artificial intelligence (AI), however, sheds the light of new strategies for hypertension management, such as remote supports from telemedicine and big data-derived prediction. There is considerable evidence demonstrating the feasibility of AI applications in hypertension management. A foreseeable trend was observed in integrating BP measurements with various wearable sensors and smartphones, so as to permit continuous and convenient monitoring. In the meantime, further investigations are advised to validate the novel prediction and prognostic tools. These revolutionary developments have made a stride toward the future model for digital management of chronic diseases. © 2021 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC. |
|
antihypertensive agent; antihypertensive therapy; artificial intelligence; blood pressure monitoring; blood pressure regulation; disease burden; feasibility study; health care cost; human; hypertension; incidence; lifestyle modification; mobile application; outcome assessment; prediction; prognosis; Review; telemedicine; trend study; validation process; aged; artificial intelligence; hypertension; telemedicine; Aged; Artificial Intelligence; Humans; Hypertension; Telemedicine |
John Wiley and Sons Inc |
15246175 |
|
33533536 |
Review |
Q2 |
909 |
5078 |
|
|